[1] Smyth S, Heron A (2006) Diabetes and obesity: the twin epidemics. Nat Med 12: 75-80
[2] Global Burden of Disease Study C (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386: 743-800
[3] National Diabetes Statistics Report, 2017. In: Centers for Disease Control and Prevention USDoHaHS (ed). Centers for Disease Control and Prevention, Atlanta, GA, p 20
[4] Geiss LS, Wang J, Cheng YLJ, et al. (2014) Prevalence and Incidence Trends for Diagnosed Diabetes Among Adults Aged 20 to 79 Years, United States, 1980-2012. Jama-J Am Med Assoc 312: 1218-1226
[5] Soderberg S, Zimmet P, Tuomilehto J, et al. (2007) Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes (Lond) 31: 1126-1133
[6] Schmidt MI, Duncan BB, Vigo A, et al. (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49: 2086-2096
[7] Gao Y, Yang Q, Zhou J, Chen L (2000) Association between leptin, insulin, and body fat distribution in 2-diabetes mellitus. Ann N Y Acad Sci 904: 542-545
[8] Denroche HC, Huynh FK, Kieffer TJ (2012) The role of leptin in glucose homeostasis. J Diabetes Investig 3: 115-129
[9] D'Souza A M, Neumann UH, Glavas MM, Kieffer TJ (2017) The glucoregulatory actions of leptin. Mol Metab 6: 1052-1065
[10] Fernandez-Formoso G, Perez-Sieira S, Gonzalez-Touceda D, Dieguez C, Tovar S (2015) Leptin, 20 years of searching for glucose homeostasis. Life Sci 140: 4-9
[11] Perry RJ, Petersen KF, Shulman GI (2016) Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis. Diabetologia 59: 933-937
[12] Toyoshima Y, Gavrilova O, Yakar S, et al. (2005) Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology 146: 4024-4035
[13] Singh P, Sharma P, Sahakyan KR, et al. (2016) Differential effects of leptin on adiponectin expression with weight gain versus obesity. Int J Obes (Lond) 40: 266-274
[14] Carpenter MA, Crow R, Steffes M, et al. (2004) Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med Sci 328: 131-144
[15] Taylor HA, Jr. (2005) The Jackson Heart Study: an overview. Ethn Dis 15: S6-1-3
[16] Liu J, Butler KR, Buxbaum SG, Sung JH, Campbell BW, Taylor HA (2010) Leptinemia and its association with stroke and coronary heart disease in the Jackson Heart Study. Clin Endocrinol (Oxf) 72: 32-37
[17] Bidulescu A, Liu J, Musani SK, et al. (2011) Association of adiponectin with left ventricular mass in blacks: the Jackson Heart Study. Circ Heart Fail 4: 747-753
[18] Shand B, Elder P, Scott R, Frampton C, Willis J (2006) Biovariability of plasma adiponectin. Clin Chem Lab Med 44: 1264-1268
[19] Davis SK, Gebreab SY, Xu R, et al. (2015) Association of adiponectin with type 2 diabetes and hypertension in African American men and women: the Jackson Heart Study. BMC Cardiovasc Disord 15: 13
[20] Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419
[21] Valeri L, Vanderweele TJ (2013) Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods 18: 137-150
[22] Valeri L, VanderWeele TJ (2015) SAS macro for causal mediation analysis with survival data. Epidemiology 26: e23-24
[23] Shpakov AO (2014) [The role of alterations in the brain signaling systems regulated by insulin, IGF-1 and leptin in the transition of impaired glucose tolerance to overt type 2 diabetes mellitus]. Tsitologiia 56: 789-799
[24] Meek TH, Morton GJ (2012) Leptin, diabetes, and the brain. Indian J Endocrinol Metab 16: S534-542
[25] Barber M, Kasturi BS, Austin ME, Patel KP, MohanKumar SM, MohanKumar PS (2003) Diabetes-induced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin. Brain Res 964: 128-135
[26] Turer AT, Scherer PE (2012) Adiponectin: mechanistic insights and clinical implications. Diabetologia 55: 2319-2326
[27] Yamauchi T, Kamon J, Waki H, et al. (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278: 2461-2468
[28] Coppari R, Bjorbaek C (2012) Leptin revisited: its mechanism of action and potential for treating diabetes. Nature reviews Drug discovery 11: 692-708
[29] Myers MG, Cowley MA, Munzberg H (2008) Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70: 537-556
[30] Al-Hamodi Z, Al-Habori M, Al-Meeri A, Saif-Ali R (2014) Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus. Diabetol Metab Syndr 6: 99
[31] Scotece M, Conde J, Lopez V, et al. (2014) Adiponectin and leptin: new targets in inflammation. Basic Clin Pharmacol Toxicol 114: 97-102
[32] Duncan BB, Schmidt MI, Pankow JS, et al. (2004) Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 53: 2473-2478
[33] Bi X, Loo YT, Henry CJ (2018) Does circulating leptin play a role in energy expenditure? Nutrition 60: 6-10
[34] Garaulet M, Perex-Llamas F, Fuente T, Zamora S, Tebar FJ (2000) Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol 143: 657-666
[35] Lonnqvist F, Wennlund A, Arner P (1997) Relationship between circulating leptin and peripheral fat distribution in obese subjects. Int J Obes Relat Metab Disord 21: 255-260
[36] Minocci A, Savia G, Lucantoni R, et al. (2000) Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord 24: 1139-1144
[37] Staiger H, Tschritter O, Machann J, et al. (2003) Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 11: 368-372
[38] Ostlund RE, Jr., Yang JW, Klein S, Gingerich R (1996) Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 81: 3909-3913
[39] Genske F, Kuhn JP, Pietzner M, et al. (2018) Abdominal fat deposits determined by magnetic resonance imaging in relation to leptin and vaspin levels as well as insulin resistance in the general adult population. Int J Obes (Lond) 42: 183-189
[40] Berglund ED, Vianna CR, Donato J, Jr., et al. (2012) Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest 122: 1000-1009
[41] Coppari R, Ichinose M, Lee CE, et al. (2005) The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab 1: 63-72
[42] Cummings BP, Bettaieb A, Graham JL, et al. (2011) Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats. Proc Natl Acad Sci U S A 108: 14670-14675
[43] Moon HS, Matarese G, Brennan AM, et al. (2011) Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance. Diabetes 60: 1647-1656
[44] McNeely MJ, Boyko EJ, Weigle DS, et al. (1999) Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 22: 65-70
[45] Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N (2007) Adipokines and risk of type 2 diabetes in older men. Diabetes Care 30: 1200-1205
[46] Ley SH, Harris SB, Connelly PW, et al. (2008) Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project. Diabetes Care 31: 1410-1415
[47] Ruige JB, Dekker JM, Blum WF, et al. (1999) Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care 22: 1097-1104
[48] Zimmet P, Hodge A, Nicolson M, et al. (1996) Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ 313: 965-969
[49] Marita AR, Sarkar JA, Rane S (2005) Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India. Mol Cell Biochem 275: 143-151